Abiomed
ABMD
#1100
Rank
NZ$27.77 B
Marketcap
$615.87
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : NZ$0.25 B

According to Abiomed's latest financial reports the company's total liabilities are NZ$0.25 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Abiomed - Total liabilities on balance sheet (from 2013 to 2022)

Total liabilities by year

Year Total liabilities Change
2022-03-31NZ$0.24 B4.24%
2021-03-31NZ$0.23 B-7.58%
2020-03-31NZ$0.25 B47.49%
2019-03-31NZ$0.17 B29.09%
2018-03-31NZ$0.13 B-4.6%
2017-03-31NZ$0.14 B75.69%
2016-03-31NZ$79.81 M28.16%
2015-03-31NZ$62.27 M45.57%
2014-03-31NZ$42.78 M8.8%
2013-03-31NZ$39.32 M16.89%
2012-03-31NZ$33.63 M-4.33%
2011-03-31NZ$35.16 M15.45%
2010-03-31NZ$30.45 M-14.36%
2009-03-31NZ$35.56 M16.99%
2008-03-31NZ$30.39 M54.39%
2007-03-31NZ$19.68 M31.68%
2006-03-31NZ$14.95 M117.36%
2005-03-31NZ$6.87 M-6.33%
2004-03-31NZ$7.34 M-34.91%
2003-03-31NZ$11.28 M-51.25%
2002-03-31NZ$23.14 M-1.55%
2001-03-31NZ$23.5 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$4.65 B 1,739.10%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$26.66 B 10,425.21%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.21 B-13.76%๐Ÿ‡บ๐Ÿ‡ธ USA